Ivory Dentin Graft™
A new bone graft derived from natural dentin
Product Description:
Ivory Dentin Graft™ is a novel, xenograft-origin bioresorbable graft material for the repair or augmentation of bone defects in dental procedures.
- Autograft: bone or dentin | Disadvantage: very limited amount, painful for bone grafting
- Allograft: bone (mainly from corpses) | Disadvantage: expensive, limited amount, risk of human-to-human disease
- Xenograft: bone origin (mainly bovine and porcine) | Opportunity: off-the-shelf, ready to use product, most common and favorable in the market mainly in Asia Pacific.
- Synthetic: variety of materials, generally hydroxyapatite | Disadvantage: non-organic materials
Play Video
- Ivory Graft Ltd. has developed Ivory Dentin Graft™ in order to expand the use of dentin‐derived material to patients where autogenic tooth material is not available
- Ivory Dentin Graft™ is powered by advantages of unique dentin structure and organic material
- Bioresorbable dentin graft: In its structure, Ivory DentinGraft™ is chemically the same as human bone. In addition to mineral phase it contains full active organic matrix
- Ivory Dentin Graft is CE Marked (MDR 2017/745)
- Intended Use: Ivory Dentin Graft™ is intended for the repair or augmentation of bone defects in dental procedures. Ivory Dentin Graft is intended for use in a clinical environment and may only be used by dentists or oral surgeons
Prof. Eitan Mijiritsky
CSO
DMD, PhD. Associate Professor, Specialist in Prosthodontics, School of Dental Medicine, Tel-Aviv University, Israel. Oral rehabilitation consultant, the Oral-Maxillo-Facial department, Sourasky Tel-Aviv Medical Center. President Elected of the European Prosthodontic Association - EPA. Board Member, the Digital Dentistry Society International - DDS. Published over 130 peer-reviewed articles.
DMD, PhD. Associate Professor, Specialist in Prosthodontics, School of Dental Medicine, Tel-Aviv University, Israel. Oral rehabilitation consultant, the Oral-Maxillo-Facial department, Sourasky Tel-Aviv Medical Center. President Elected of the European Prosthodontic Association - EPA. Board Member, the Digital Dentistry Society International - DDS. Published over 130 peer-reviewed articles.
Dr. Lari Sapoznikov
CCO
DMD. Veteran Implantologist and prosthodontist (private clinic, Tel-Aviv, since 1992). Specialist in Basal Implantology, University of Nice, France. Inventor of the concept using extracted tooth as autologous graft and of the "Smart Dentin Grinder". Member of the Israeli and the German Associations of Oral Implantology. Fellow of the International Congress of Oral implantology. Member of the faculty of dentistry of the Royal College of Surgeons in Ireland, England and Scotland.
DMD. Veteran Implantologist and prosthodontist (private clinic, Tel-Aviv, since 1992). Specialist in Basal Implantology, University of Nice, France. Inventor of the concept using extracted tooth as autologous graft and of the "Smart Dentin Grinder". Member of the Israeli and the German Associations of Oral Implantology. Fellow of the International Congress of Oral implantology. Member of the faculty of dentistry of the Royal College of Surgeons in Ireland, England and Scotland.
Meir Sahar
General Manager
Serial Dental Care entrepreneur, with 25 years of hands-on experience. Co-founder, DentQ and CTdent (world's largest chain of dental imaging centers). Responsible for the first even Dental PACS.
Co-founded the Smart Dentin Grinder initiative.
Co-founded the Smart Dentin Grinder initiative.
Dr. Martin Stern
Scientific Advisor
DDS (NYU). Diplomate, American Board of Oral Implantology. Expert, Oral Implantology, International College of Oral Implantology. International Member, American Academy of Periodontology.
DDS (NYU). Diplomate, American Board of Oral Implantology. Expert, Oral Implantology, International College of Oral Implantology. International Member, American Academy of Periodontology.
Eyal Miller
CEO
Senior manager with over 25 years in the Medical Device arena. Held executive positions as GM at Nucleix, CEO at Common Sense, a highly innovative Gynecology Medical Device (led the company to buyout) and Head of Healthcare Division at Stratasys (Nasdaq:SSYS)
Senior manager with over 25 years in the Medical Device arena. Held executive positions as GM at Nucleix, CEO at Common Sense, a highly innovative Gynecology Medical Device (led the company to buyout) and Head of Healthcare Division at Stratasys (Nasdaq:SSYS)
Liya Greenberg
QA/RA Director
M.Sc, with 15 years QA experience in the medical device and pharmaceutical industry
M.Sc, with 15 years QA experience in the medical device and pharmaceutical industry
Prof. Gerard Scortecci
Scientific Advisor
DDS, PhD. Scientific Director, postgraduate basal implantology program, Nice-Sophia University. Clinical prof. of periodontology, USC. Was the president of the international Congress of Oral Implantologists. Fellow, ACD and ICD. Diplomate, ICOI. Author of "Basal Implantology"(2019).
DDS, PhD. Scientific Director, postgraduate basal implantology program, Nice-Sophia University. Clinical prof. of periodontology, USC. Was the president of the international Congress of Oral Implantologists. Fellow, ACD and ICD. Diplomate, ICOI. Author of "Basal Implantology"(2019).
Samantha J. Talpir
VP Marketing
25 years of international marketing experience. Specializes in early stage medical device startups and innovation.
25 years of international marketing experience. Specializes in early stage medical device startups and innovation.
Dr. Nathalie Frumkin
Head of Clinical Training
Expert in periodontology with over 20 dental years experience. Acknowledged as a periodontologist by the European Federation of Periodontology (EFP). Holds MSc in human genetics. Active member and lecturer at international and national conferences, and has published in international periodontal journals.
Expert in periodontology with over 20 dental years experience. Acknowledged as a periodontologist by the European Federation of Periodontology (EFP). Holds MSc in human genetics. Active member and lecturer at international and national conferences, and has published in international periodontal journals.
Leadership Team
Ivory Graft is led by expert, professional and great people
Quality Policy Statement:
“The Management and staff of Ivory Graft Ltd. are committed to the development, production and commercialization of safe and effective dental products that comply with national and international applicable standards and provide significant clinical benefit to patients and clinicians who use them.”
Contact Us
★★★★★
Read More
לורם איפסום דולור סיט אמט, קונסקטורר אדיפיסינג אלית לורם איפסום דולור סיט אמט, קונסקטורר אדיפיסינג אלית. סת אלמנקום ניסי נון ניבאה. דס איאקוליס וולופטה דיאם. וסטיבולום אט דולור, קראס אגת לקטוס וואל אאוגו וסטיבולום סוליסי טידום בעליק. ליבם סולגק. בראיט ולחת צורק מונחף, בגורמי מגמש. תרבנך וסתעד לכנו סתשם השמה – לתכי מורגם בורק? לתיג ישבעס.
★★★★★
Read More
לורם איפסום דולור סיט אמט, קונסקטורר אדיפיסינג אלית לורם איפסום דולור סיט אמט, קונסקטורר אדיפיסינג אלית. סת אלמנקום ניסי נון ניבאה. דס איאקוליס וולופטה דיאם. וסטיבולום אט דולור, קראס אגת לקטוס וואל אאוגו וסטיבולום סוליסי טידום בעליק. ליבם סולגק. בראיט ולחת צורק מונחף, בגורמי מגמש. תרבנך וסתעד לכנו סתשם השמה – לתכי מורגם בורק? לתיג ישבעס.
★★★★★
Read More
לורם איפסום דולור סיט אמט, קונסקטורר אדיפיסינג אלית לורם איפסום דולור סיט אמט, קונסקטורר אדיפיסינג אלית. סת אלמנקום ניסי נון ניבאה. דס איאקוליס וולופטה דיאם. וסטיבולום אט דולור, קראס אגת לקטוס וואל אאוגו וסטיבולום סוליסי טידום בעליק. ליבם סולגק. בראיט ולחת צורק מונחף, בגורמי מגמש. תרבנך וסתעד לכנו סתשם השמה – לתכי מורגם בורק? לתיג ישבעס.
Previous
Next
